Efflux pumps in bacteria: Overview, clinical relevance, and potential pharmaceutical target

Expert Opinion on Investigational Drugs

Volumn 7, Issue 2, 1998, Pages 199-217

  Lawrence, L E ^a   Barrett, J F ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

Antibacterial agents; Drug accumulation; Efflux pumps; Multi drug resistance

Indexed keywords

AMINOGLYCOSIDE; ANTIINFECTIVE AGENT; CEPHALOSPORIN DERIVATIVE; ERYTHROMYCIN; NAPHTHOQUINONE; NORFLOXACIN; QUINOLONE DERIVATIVE; TETRACYCLINE;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; BACILLUS SUBTILIS; BACTERIAL INFECTION; DRUG ACCUMULATION; DRUG DEVELOPMENT; DRUG TRANSPORT; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; HUMAN; MULTIDRUG RESISTANCE; MYCOBACTERIUM; NEISSERIA GONORRHOEAE; NONHUMAN; PSEUDOMONAS AERUGINOSA; REVIEW; STAPHYLOCOCCUS; STREPTOCOCCUS; STREPTOMYCES;

EID: 0031964213     PISSN: 13543784     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543784.7.2.199     Document Type: Review

References (167)